25 Results for "

DB cells

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "DB cells" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-135797A
CAS No.: 2369663-93-2
Purity:  ≥98.0%
Target:  

Apoptosis

Research Areas:  

Cancer

DB1976 dihydrochloride is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. DB1976 dihydrochloride potently inhibits PU.1 binding (IC50 of 10 nM) and strongly inhibits the PU.1/DNA complex (with high DB1976-λB affinity, KD of 12 nM) in vitro. DB1976 dihydrochloride has apoptosis-inducing effect .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-124629
CAS No.: 2170606-74-1
Purity:  99.48%
Target:  

Apoptosis

Research Areas:  

Cancer

DB2313 is a potent inhibitor of transcription factor PU.1. DB2313 inhibits PU.1-dependent reporter gene transactivation with an IC50 of 5 μM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis in acute myeloid leukemia (AML) cells and has anticancer effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18555
CAS No.: 1258275-73-8
TMPA is a high-affinity Nur77 antagonist that binds to Nur77 leading to the release and shuttling of LKB1 in the cytoplasm to activate AMPKα. TMPA effectively lowers blood glucose and attenuates insulin resistance in type II db/db, high-fat diet and streptozotocin-induced diabetic mice. TMPA reduces RICD (restimulation-induced cell death) in human T cells, can also be used in studies of cancer and T-cell apoptosis dysregulation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112234
CAS No.: 17094-01-8
Synonyms: Sepiapterin
L-Sepiapterin (Sepiapterin), is a phenylalanine hydroxylase activator, is a precursor of the endothelial nitric oxide synthase (eNOS) cofactor tetrahydrobiopterin (BH4). L-Sepiapterin improves endothelial dysfunction in small mesenteric arteries from db/db mice, and induces angiogenesis. L-Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70 S6K-dependent VEGFR-2 expression. L-Sepiapterin can be used for the study of hyperphenylalaninemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124676A
CAS No.: 1366126-19-3
Purity:  99.13%
Target:  

Apoptosis

Research Areas:  

Cancer

DB2115 tetrahydrochloride is a highly selective PU.1 inhibitor that suppresses the binding of PU.1 to DNA (IC50: 2.3 nM). DB2115 tetrahydrochloride can inhibit tumor cell proliferation and induce apoptosis. DB2115 tetrahydrochloride can be used in the research of tumors such as leukemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P0323A
Synonyms: LCMV GP(33-41) C-peptide TFA
Target:  

Arenavirus

Research Areas:  

Infection

GP(33-41) TFA, a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus. GP(33-41) TFA can upregulate H-2D b molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM .
loading...
    loading...
Cat. No.: HY-122623A
Purity:  99.43%
Target:  

Apoptosis

Research Areas:  

Cancer

DB818 dihydrochloride is the dihydrochloride salt form of DB818 (HY-122623). DB818 dihydrochloride is an inhibitor for Homeobox A9 (HOXA9). DB818 dihydrochloride reduces the formation of HOXA9-DNA complexes, inhibits the growth and induces apoptosis in AML cell lines OCI/AML3, MV4-11, and THP-1 .
loading...
    loading...
Cat. No.: HY-135797
CAS No.: 1557397-51-9
Target:  

Apoptosis

Research Areas:  

Cancer

DB1976 is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. DB1976 potently inhibits PU.1 binding (IC50 of 10 nM) and strongly inhibits the PU.1/DNA complex (with high DB1976-λB affinity, KD of 12 nM) in vitro. DB1976 has apoptosis-inducing effect .
loading...
    loading...
Cat. No.: HY-W168754
CAS No.: 16296-42-7
Target:  

MHC

Research Areas:  

Others

DB28 is a novel MR1 ligand. DB28 decreases cell surface expression of MR1 and competitively inhibits activation of MAIT cells by agonist ligands .
loading...
    loading...
Cat. No.: HY-P11084
CAS No.: 256952-63-3
Target:  

MHC

Research Areas:  

Inflammation/Immunology Cancer

WT1 126-134 peptide is a Wilms' tumor oncogene protein (WT1) peptide (RMFPNAPYL). WT1 126-134 peptide is presented by HLA-A0201 and induces cytotoxic CD8 T cells capable of killing WT1+ positive tumor cells. WT1 126-134 can form stable complexes with the H-2Db (mouse) or HLA-A0201 (human) molecules. WT1 126-134 peptide/HLA-A0201 complex has an extremely high affinity (Kd = 0.2 nM) with the humanized monoclonal antibody (IgG1). WT1 126-134 peptide can be used as a vaccine for T cells or as a target for antibodies .
loading...
    loading...
Cat. No.: HY-137343
CAS No.: 2769753-59-3
Purity:  ≥98.0%
Research Areas:  

Others

DB-0646 is a multi-target PROTAC degrader that degrades over 125 distinct kinases in various cell lines, with its degradation process dependent on the activity of p97. DB-0646 induces ubiquitination and degradation of GCK, BUB1 and YES1 .
loading...
    loading...
Cat. No.: HY-17538A
CAS No.: 2319647-97-5
Target:  

PGC-1α

Research Areas:  

Metabolic Disease

ZLN005 (hydrochloride) is a peroxisome proliferator-activated receptor-g coactivator-1a (PGC-1α) activator. ZLN005 (hydrochloride) can stimulate the expression of PGC-1α and downstream genes in skeletal muscle cells, improve glucose utilization and fatty acid oxidation. ZLN005 (hydrochloride) can increase the transcription of PGC-1α and downstream genes in skeletal muscle of diabetic db/db mice, increase fat oxidation and improve glucose tolerance, pyruvate tolerance and insulin sensitivity .
loading...
    loading...
Cat. No.: HY-P0323
CAS No.: 161928-86-5
Synonyms: LCMV GP(33-41) C-peptide
Target:  

Arenavirus

Research Areas:  

Infection

GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2D b molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM .
loading...
    loading...
Cat. No.: HY-173344
Target:  

p38 MAPK

Research Areas:  

Neurological Disease

DB-10 is a pro-agent of 3-nbutylphthalide (NBP) (HY-B0647). DB-10 has significantly high uptake ability via pyrilamine cationic transporters in the temperature and energy dependent manner in cells. DB-10 improves the survival rate of cells. DB-10 could rapidly convert into active original agent and increase the accumulation in the brain in vivo. DB-10 can be used for ischemic stroke study .
loading...
    loading...
Cat. No.: HY-124629A
CAS No.: 2170606-75-2
Target:  

Apoptosis

Research Areas:  

Cancer

DB2313 tetrahydrochloride is a potent transcription factor PU.1 inhibitor with an apoptosis of 14 nM. DB2313 tetrahydrochloride disrupts the interaction of PU.1 with target gene promoters. DB2313 tetrahydrochloride induces apoptosis of acute myeloid leukemia (AML) cells, and has anticancer effects .
loading...
    loading...
Cat. No.: HY-122115
CAS No.: 669749-45-5
Research Areas:  

Cancer

DCE_42 is a potent EZH2 inhibitor with an IC50 value of 22.6 µM. DCE_42 inhibits cell proliferation and has the potential for the research of lymphoma .
loading...
    loading...
Cat. No.: HY-114569A
CAS No.: 1054549-71-1
Purity:  98.75%
Research Areas:  

Cancer

DH-8P-DB is an anticancer candidate and exhibits cytotoxicity against colon cancer cells .
loading...
    loading...
Cat. No.: HY-P10010
CAS No.: 1623027-80-4
Target:  

Galectin

Research Areas:  

Cancer

DB21, Galectin-1 Antagonist is a dibenzofuran conjugated peptidomimetic that acts as an allosteric inhibitor of galectin-1 (GAL1)binding to cell surface glycans. DB21, Galectin-1 Antagonis increases inhibition of angiogenesis and tumour growth in melanoma, lung adenocarcinoma and ovarian cancer models .
loading...
    loading...
Cat. No.: HY-P991983

Target:  

ADC Antibodies

Research Areas:  

Cancer

DB-1310 Antibody is a monoclonal antibody inhibitor targeting HER3. DB-1310 Antibody can be used to synthesize the antibody-drug conjugate (ADC) DB-1310. DB-1310 Antibody is applicable to research related to HER3-positive solid tumors, non-small cell lung cancer, breast cancer, colon cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-124693
CAS No.: 869767-86-2
Target:  

Apoptosis

Research Areas:  

Cancer

DB1055 is a HOXA9 inhibitor that competes with HOXA9 binding to DNA (blocking its DNA interaction activity). DB1055 induces in vitro cell growth reduction, cell apoptosis, and differentiation in human acute myeloid leukemia (AML) cells. DB1055 leads to monocyte-to-macrophage differentiation and exhibits antileukemic activities in a human THP-1 AML in vivo model. DB1055 does not impact human CD34+ bone marrow cells. DB1055 can be used for the research of acute myeloid leukemia[1].
loading...
    loading...